• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用工具变量估计决策相关的比较效应。

Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.

作者信息

Basu Anirban

机构信息

Departments of Health Services and Pharmacy, University of Washington, Seattle, 1959 NE Pacific St, Box 357660, Seattle, WA 98195-7660, USA.

出版信息

Stat Biosci. 2011 Sep;3(1):6-27. doi: 10.1007/s12561-011-9033-6.

DOI:10.1007/s12561-011-9033-6
PMID:22010051
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3193796/
Abstract

Instrumental variables methods (IV) are widely used in the health economics literature to adjust for hidden selection biases in observational studies when estimating treatment effects. Less attention has been paid in the applied literature to the proper use of IVs if treatment effects are heterogeneous across subjects. Such a heterogeneity in effects becomes an issue for IV estimators when individuals' self-selected choices of treatments are correlated with expected idiosyncratic gains or losses from treatments. We present an overview of the challenges that arise with IV estimators in the presence of effect heterogeneity and self-selection and compare conventional IV analysis with alternative approaches that use IVs to directly address these challenges. Using a Medicare sample of clinically localized breast cancer patients, we study the impact of breast-conserving surgery and radiation with mastectomy on 3-year survival rates. Our results reveal the traditional IV results may have masked important heterogeneity in treatment effects. In the context of these results, we discuss the advantages and limitations of conventional and alternative IV methods in estimating mean treatment-effect parameters, the role of heterogeneity in comparative effectiveness research and the implications for diffusion of technology.

摘要

工具变量法(IV)在卫生经济学文献中被广泛用于在估计治疗效果时调整观察性研究中隐藏的选择偏差。在应用文献中,如果治疗效果在不同受试者之间存在异质性,那么对于工具变量的正确使用关注较少。当个体对治疗的自我选择与治疗预期的特异收益或损失相关时,这种效果异质性就成为工具变量估计量的一个问题。我们概述了在存在效果异质性和自我选择的情况下工具变量估计量所面临的挑战,并将传统的工具变量分析与使用工具变量直接应对这些挑战的替代方法进行比较。利用医疗保险中临床局限性乳腺癌患者的样本,我们研究了保乳手术加放疗与乳房切除术对3年生存率的影响。我们的结果表明,传统的工具变量结果可能掩盖了治疗效果中重要的异质性。结合这些结果,我们讨论了传统和替代工具变量方法在估计平均治疗效果参数方面的优缺点、异质性在比较效果研究中的作用以及对技术传播的影响。

相似文献

1
Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.使用工具变量估计决策相关的比较效应。
Stat Biosci. 2011 Sep;3(1):6-27. doi: 10.1007/s12561-011-9033-6.
2
Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients.在存在异质性和自我选择情况下使用工具变量:乳腺癌患者治疗的应用
Health Econ. 2007 Nov;16(11):1133-57. doi: 10.1002/hec.1291.
3
An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.对医疗保险人群中局部乳腺癌治疗结果的探索性工具变量分析。
Health Econ. 2003 Mar;12(3):171-86. doi: 10.1002/hec.710.
4
The productivity of mental health care: an instrumental variable approach.精神卫生保健的生产力:一种工具变量法。
J Ment Health Policy Econ. 1999 Jun 1;2(2):59-71. doi: 10.1002/(sici)1099-176x(199906)2:2<59::aid-mhp47>3.0.co;2-j.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Assessing the ability of an instrumental variable causal forest algorithm to personalize treatment evidence using observational data: the case of early surgery for shoulder fracture.评估工具变量因果森林算法利用观察数据进行个体化治疗证据的能力:以肩部骨折早期手术为例。
BMC Med Res Methodol. 2022 Jul 11;22(1):190. doi: 10.1186/s12874-022-01663-0.
7
Local Instrumental Variable Methods to Address Confounding and Heterogeneity when Using Electronic Health Records: An Application to Emergency Surgery.利用电子健康记录解决混杂和异质性的局部工具变量方法:在急诊手术中的应用。
Med Decis Making. 2022 Nov;42(8):1010-1026. doi: 10.1177/0272989X221100799. Epub 2022 May 24.
8
Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.纵向观察性研究因果推断的工具变量与逆概率加权法
Stat Methods Med Res. 2004 Feb;13(1):17-48. doi: 10.1191/0962280204sm351ra.
9
10
Vesicoureteral Reflux膀胱输尿管反流

引用本文的文献

1
Assessing the properties of patient-specific treatment effect estimates from causal forest algorithms under essential heterogeneity.评估因果森林算法在本质异质性下对特定于患者的治疗效果估计的特性。
BMC Med Res Methodol. 2024 Mar 13;24(1):66. doi: 10.1186/s12874-024-02187-5.
2
Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder.比较工具变量在丁丙诺啡/纳洛酮或美沙酮治疗阿片类药物使用障碍中的分配效果。
Epidemiology. 2024 Mar 1;35(2):218-231. doi: 10.1097/EDE.0000000000001697. Epub 2023 Jan 30.
3
Mendelian Randomization analysis of the causal effect of adiposity on hospital costs.肥胖对医院费用因果效应的孟德尔随机化分析。
J Health Econ. 2020 Mar;70:102300. doi: 10.1016/j.jhealeco.2020.102300. Epub 2020 Jan 25.
4
Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes.2型糖尿病患者基础胰岛素治疗的依从性:一项关于成本和患者结局的回顾性队列研究
Diabetes Ther. 2018 Jun;9(3):1099-1111. doi: 10.1007/s13300-018-0421-5. Epub 2018 Apr 11.
5
A Framework for Prioritizing Research Investments in Precision Medicine.精准医学研究投资优先级框架。
Med Decis Making. 2016 Jul;36(5):567-80. doi: 10.1177/0272989X15610780. Epub 2015 Oct 26.
6
ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.使用工具变量估计以患者为中心的治疗(PeT)效果:在评估前列腺癌治疗中的应用。
J Appl Econ (Chichester Engl). 2014 June/July;29(4):671-691. doi: 10.1002/jae.2343.
7
Adjusting for geographic variation in observational comparative effectiveness studies: a case study of antipsychotics using state Medicaid data.观察性比较效果研究中地理差异的调整:一项使用州医疗补助数据的抗精神病药物案例研究
BMC Health Serv Res. 2014 Aug 27;14:355. doi: 10.1186/1472-6963-14-355.
8
Heterogeneity in action: the role of passive personalization in comparative effectiveness research.行动中的异质性:被动个性化在比较效果研究中的作用
Health Econ. 2014 Mar;23(3):359-73. doi: 10.1002/hec.2996. Epub 2013 Oct 9.

本文引用的文献

1
Individualization at the heart of comparative effectiveness research: the time for i-CER has come.个体化是比较效果研究的核心:开展个体化比较效果研究(i-CER)的时机已经到来。
Med Decis Making. 2009 Nov-Dec;29(6):NP9-NP11. doi: 10.1177/0272989X09351586.
2
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.类似随机试验那样分析的观察性研究:绝经后激素治疗与冠心病的应用
Epidemiology. 2008 Nov;19(6):766-79. doi: 10.1097/EDE.0b013e3181875e61.
3
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.两阶段残差包含估计:解决健康计量经济学建模中的内生性问题
J Health Econ. 2008 May;27(3):531-43. doi: 10.1016/j.jhealeco.2007.09.009. Epub 2007 Dec 4.
4
Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients.在存在异质性和自我选择情况下使用工具变量:乳腺癌患者治疗的应用
Health Econ. 2007 Nov;16(11):1133-57. doi: 10.1002/hec.1291.
5
Lessons learned from the COURAGE trial: generalizability, limitations, and implications.从COURAGE试验中吸取的经验教训:普遍性、局限性及启示
Prev Cardiol. 2007 Summer;10(3):117-20. doi: 10.1111/j.1520-037x.2007.06100.x.
6
Performance of propensity score calibration--a simulation study.倾向得分校准的性能——一项模拟研究。
Am J Epidemiol. 2007 May 15;165(10):1110-8. doi: 10.1093/aje/kwm074. Epub 2007 Mar 28.
7
Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods.存在治疗选择偏倚时观察性研究的分析:使用倾向评分和工具变量法分析侵入性心脏管理对急性心肌梗死生存率的影响
JAMA. 2007 Jan 17;297(3):278-85. doi: 10.1001/jama.297.3.278.
8
Doubly robust estimation in missing data and causal inference models.缺失数据与因果推断模型中的双重稳健估计
Biometrics. 2005 Dec;61(4):962-73. doi: 10.1111/j.1541-0420.2005.00377.x.
9
Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa.早期乳腺癌保乳手术的应用是否不足?来自爱荷华州II期患者的工具变量证据。
Health Serv Res. 2003 Dec;38(6 Pt 1):1385-402. doi: 10.1111/j.1475-6773.2003.00184.x.
10
Economic evaluation of breast cancer treatment: considering the value of patient choice.乳腺癌治疗的经济评估:考量患者选择的价值。
J Clin Oncol. 2003 Mar 15;21(6):1139-46. doi: 10.1200/JCO.2003.03.126.